Feds assert rights to march-in on drug patents over price : Shots

To lower drug prices, the Biden administration is looking to assert its authority to license drug patents that rely on government-funded research to drugmakers that would offer cheaper medicines.

Related Keywords

United States ,Washington ,American ,Megan Van Etten ,James Love ,Harvard Sarpatwari ,Department Of Commerce ,White House National Economic Advisor Lael Brainard ,Harvard Medical School ,Knowledge Ecology International ,Human Services ,Department Of Health ,National Institutes Of Health ,Program On Regulation ,Getty Images ,House National Economic Advisor Lael Brainard ,Bayh Dole Act ,Van Etten ,National Institutes ,